Bio-Techne Corp.
Here’s whether Bio-Techne Corp. (TECH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+7.35% over 10 days); strong 1-year return of +34.7%; 3-month momentum positive (+67.2%). Concerns: RSI 72 — overbought, elevated pullback risk; declining volume on rally — weak conviction (0.78x 30d avg). Currently 0.0% off its 52-week high. Score: +4/7.
TECH is in a confirmed uptrend, trading above both its 50-day ($66.93) and 200-day ($60.10) moving averages. With an RSI of 71.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +34.7% compares to +20.4% for SPY (beat the market by 14.3%).